Table 2 The potential risk factors for residual tumors after initial incomplete staging surgery
From: Surgical staging of apparent early-stage ovarian mucinous carcinoma
Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
P-value | OR (95%CI) | P-value | OR (95%CI) | |
Age | 0.288 | 1.036 (0.970–1.106) | ||
Body mass index | 0.829 | 0.981 (0.820–1.172) | ||
During the pregnancy | 0.063 | 6.000 (0.907–39.700) | 0.267 | 3.623 (0.373–35.190) |
A history of ovarian mucinous tumor | 0.199 | 2.885 (0.573–14.526) | ||
CEA elevated at the time of diagnosis | 0.122 | 8.000 (0.572–111.958) | ||
CA199 elevated at the time of diagnosis | 0.590 | 1.600 (0.289–8.859) | ||
CA125 elevated at the time of diagnosis | 0.247 | 0.266 (0.028–2.501) | ||
Laparoscopy at first-step surgery | 0.722 | 1.227 (0.396–3.800) | ||
Ascites | 0.896 | 0.860 (0.090–8.197) | ||
Tumor size | 0.847 | 1.008 (0.928–1.096) | ||
Bilateral ovary involvement | 0.036 | 12.231 (1.175–127.359) | 0.403 | 3.028 (0.226–40.558) |
Ovarian cystectomy | 0.004 | 6.129 (1.808–20.776) | 0.016 | 4.932 (1.347–18.058) |
With malignant mural nodules | 0.382 | 3.533 (0.208–59.901) | ||
Expansile subtype tumor | 0.420 | 1.750 (0.449–6.825) | ||
Poorly differentiated tumor | 0.341 | 2.234 (0.428–11.671) | ||
Time interval between surgeries | 0.598 | 1.002 (0.996–1.008) | ||